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Primary heart tumours affect less than 1% of dogs. Due to their rare inci-
dence, every research showing the frequency of cardiac tumours is valuable. Rou-
tine diagnostics is often complemented with immunohistochemical analysis. This 
study was conducted on 110 patient records from all veterinary faculties in Poland 
from dogs diagnosed with heart tumours between 1970 and 2014. The dogs’ age, 
breed and sex with tumour localisation and histopathological diagnosis were ana-
lysed. Because of its most common incidence, samples of haemangiosarcoma un-
derwent further examination with assessment of the expression of cell markers 
that have not been evaluated earlier (i.e. minichromosome maintenance proteins 
and beta-catenin). We noted 111 tumours including 88.3% malignant and 10.8% 
benign ones. Haemangiosarcoma and aortic body tumour were the most frequent 
cardiac neoplasms in the dogs examined (45.9% and 27.9% of all tumours, re-
spectively). Immunohistochemical analysis of haemangiosarcoma showed a posi-
tive expression of all markers examined. CD31, vimentin, and beta-catenin 
showed a positive reaction in all 11 samples examined. At least one proliferative 
marker (Ki-67, MCM-3 or MCM-7) showed a positive reaction in each sample. 
MCM-3 showed a higher expression than the two other proliferative markers (P = 
0.006), but only Ki-67 showed a positive correlation with the mitotic index (P < 
0.05, r = 0.89). Although beta-catenin, MCM-3 and MCM-7 showed a positive 
reaction in the haemangiosarcomas examined, their usefulness as diagnostic and 
prognostic factors should be a topic of further research.  
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Primary heart tumours are a rare cardiac condition affecting less than 1% 
of humans and animals (Lam et al., 1993; Ware and Hopper, 1999; Agaimy et 
al., 2012). Regardless of their rare occurrence, cardiac tumours often cause se-
vere clinical symptoms including signs of heart failure, arrhythmias, sudden 
death, or non-specific signs such as anorexia or apathy (Ware and Hopper, 1999; 
Aupperle et al., 2007; Rajagopalan et al., 2013). The clinical examinations used 
for the diagnosis of cardiac tumours (including echocardiography, pericardiocen-
tesis, and tumour biopsy) are often characterised by insufficient accuracy or high 
risk (Rajagopalan et al., 2013). Only the histopathological examination of heart 
tumour specimens is suitable for the precise recognition of cardiac neoplasms. 
The published frequency of different cardiac neoplasms depends on the 
examined population but there is agreement in the literature that in dogs malig-
nant tumours are more common than benign neoplasms, with haemangiosarcoma 
(HSA) being the most frequent (Ware and Hopper, 1999; Aupperle et al., 2007). 
HSA, as a prevalent tumour both in humans and in dogs, was examined for the 
expression of several cell markers including but not restricted to CD31, FVIIIRA, 
Ki-67, p53 protein, vimentin, SMA, desmin, S-100 protein, actin, and CD117 
(Ferrer et al., 1995; Bertazzolo et al., 2005; Kim et al., 2008; Sabattini and Bet-
tini, 2009; Ge et al., 2011). 
Both CD31 and FVIIIRA are specific for normal and neoplastic endothelial 
cells, yet they do not allow for discrimination between cells originating from 
lymphatic and blood vessels. Simultaneously, the expression of CD31, as com-
pared to FVIIIRA, is stronger and less diffuse, which suggests a higher diagnostic 
value of the first-mentioned protein (Ferrer et al., 1995; Bertazzolo et al., 2005). 
Vimentin is a component of the cytoskeleton of mesenchymal cells, show-
ing an expression both in normal and neoplastic endothelial cells (Sabattini and 
Bettini, 2009). 
Ki-67 is a cell proliferation marker that is expressed in all phases of the 
cell cycle except G0 and is routinely used as a diagnostic tool (Gambichler et al., 
2009; Kreuter et al., 2009). 
Due to the lack of information about the expression of beta-catenin and 
Mini-Chromosome Maintenance (MCM) proteins in canine HSA, we expanded 
the examination protocol of that neoplasm with the aforementioned proteins. 
Those markers have been examined in recent years on various neoplasms to de-
termine their usefulness as diagnostic and prognostic factors (Nowak et al., 
2007a,b; Gambichler et al., 2009; Kreuter et al., 2009; Lau et al., 2010; Saydam 
et al., 2010; Stein et al., 2011). 
Beta-catenin is an intercellular protein responsible for two important phe-
nomena: intercellular adhesion (together with cadherins) and transfer of extracel-
lular-initiated Wnt signals to the cell nucleus. The Wnt signalling pathway is 
connected among others with cell proliferation and differentiation (Nowak et al., 
2007a; Stein et al., 2011). In normal cells, beta-catenin expression is limited to 
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the cell membrane, while in neoplastic cells it accumulates in the cytoplasm and, 
to a lesser extent, in the cell nucleus. Changes in the distribution of beta-catenin 
associated with alterations in the cadherin-catenin complex result in disorders in 
cell adhesion (cells are released more easily from the primary tumour to form 
metastases), limitation of cell differentiation, and increased tumour invasiveness. 
Moreover, the accumulation of beta-catenin in the cell nucleus may lead to al-
terations in the cell cycle and, in consequence, to more intense proliferation and 
neoplastic transformation (Nowak et al., 2007a,b; Stein et al., 2011). 
The MCM proteins 2–7 function as licensing components for the S-phase 
of the cell cycle. They are proliferative markers like Ki-67 (Gambichler et al., 
2009; Kreuter et al., 2009; Lau et al., 2010). 
Each new marker helps us understand the pathogenesis of a tumour better 
and improve the diagnostic and therapeutic possibilities. 
The aims of this study were to determine (1) the epidemiology of cardiac 
tumours in dogs from Poland and (2) the expression of selected cell markers in 
HSA as the most frequent cardiac neoplasm in dogs. 
 
 
Materials and methods 
The research was done retrospectively on the basis of gross and histopa-
thological examination records. Specimens from 110 dogs with end-stage neo-
plastic disease, either collected during routine necropsy or received from private 
clinics, were subjected to pathological examination during the 44-year period be-
tween 1970 and 2014 at all veterinary faculties in Poland. 
For histopathological analysis, the sections were fixed in 7% buffered 
formalin, dehydrated, and embedded in paraffin blocks. They were stained with 
haematoxylin and eosin (HE). If needed, immunohistochemical techniques were 
applied to complete the diagnosis. The dogs’ age, sex, breed, tumour localisation, 
malignancy, and histological type served for classification. 
Because of the most common incidence of haemangiosarcoma, paraffin 
blocks of 11 samples of HSA from the last two years underwent additional im-
munohistochemical analysis including – apart from the routinely used CD31, 
vimentin and Ki-67 – beta-catenin, MCM-3 and MCM-7 expression. No other 
types of cardiac tumours were presented with a sufficient number of samples in 
the last two years to provide reliable comparisons by expanded immunohisto-
chemical analysis. Specimens older than two years were excluded from extended 
immunohistochemical analysis due to the possibility of false negative results. 
The analysis was performed on 4-µm-thick paraffin sections placed on silanised 
microscope slides (DAKO, Glostrup, Denmark) using a routine procedure. Sec-
tions were overlaid with primary antibodies including Mouse Monoclonal Anti-
Human Ki-67 – clone MIB-1 (DAKO, Denmark), diluted 1:50; Rabbit Mono-
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clonal Anti-Human MCM-3 – clone EP202 (BioSB, USA), diluted 1:50; Mouse 
Monoclonal Anti-Human MCM-7 – clone 101 (DAKO, Denmark), diluted 1:50; 
Mouse Monoclonal Anti-Human Beta-Catenin – clone β-Catenin-1 (DAKO, 
Denmark), diluted 1:100; Mouse Monoclonal Anti-Vimentin – clone V9 (DAKO, 
Denmark), diluted 1:50; Mouse Monoclonal Anti-Human CD31, Endothelial 
Cell – clone JC70A, diluted 1:100; all incubated for 30 min at room temperature. 
Sections were counterstained with haematoxylin (Sigma-Aldrich, St. Louis, MO, 
USA). Normal heart specimens stained according to the above-mentioned proto-
col served as positive controls; sections immunostained in the absence of a pri-
mary antibody were used as negative controls. 
Photomicrographs of the tumours examined were subjected to computer-
assisted image analysis, using a computer coupled to an Olympus BX53 optical 
microscope equipped with an Olympus Color View IIIa digital camera (Olympus, 
Japan). The analysis was performed with Cell^A software (Olympus Soft Imaging 
Solution GmbH, Germany). 
The expression of CD31, vimentin and β-catenin was appraised using the 
modified semiquantitative IRS scale according to Remmele and Stegner (1987). 
The expression of Ki-67, MCM-3 and MCM-7 was evaluated quantitatively by 
estimation of the percentage of neoplastic cells showing positive reaction [0–5% = 
no reaction (–), 6–25% = weak reaction (+), 26–50% = moderate reaction (++), 
above 50% = intense reaction (+++)]. Expression of the markers examined was 
evaluated in 20 randomly chosen view fields per slide, and an average value for 
each slide was calculated. 
The data were subjected to statistical analysis with Statistica PL for Win-
dows 10.0 software using tests including Spearman’s correlation test, Mann–
Whitney U analysis, Friedman’s analysis of variance (ANOVA), Kruskal–Wallis 
analysis, and chi-square analysis. Statistical significance was set at P ≤ 0.05. 
 
 
Results 
In the period 1970 through 2014, a total of 111 cardiac neoplasms were 
examined (including two tumours from one dog). The number of diagnosed tu-
mours increased with time (Fig. 1). 
Among the cases studied, 12/111 (10.8%) benign and 98/111 (88.3%) ma-
lignant tumours were determined. In one case it was impossible to establish an 
accurate histopathological diagnosis. 
The benign neoplasms included seven fibromas (6.3% of all tumours, 
58.3% of benign tumours), four myxomas (3.6% of all tumours, 33.3% of benign 
tumours), and one case of rhabdomyoma (0.1% of all tumours, 8.3% of benign 
tumours) (Fig. 2). 
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Fig. 1. Number of cardiac tumours diagnosed by year between 1970 and 2014 
 
Fig. 2. Frequency of cardiac tumours diagnosed in the dogs examined (n = 111) 
 
The malignant neoplasms included 51 HSA (45.9% of all tumours, 52% of 
malignant tumours, including 14 cases in German Shepherds), 31 aortic body 
tumours (ABT, 27.9% of all tumours, 31.6% of malignant tumours, including 13 
cases in Boxer dogs), four non-differentiated sarcomas (3.6% of all tumours, 
4.1% of malignant tumours), and three or less cases of other tumours (Fig. 2). 
Due to the retrospective character of the study, in some of the animals it 
was impossible to determine all of the data. In 47/111 tumours (42.7%) an accu-
rate tumour localisation was lacking, with only ‘heart tumour’ or ‘cardiac muscle 
tumour’ existing as a description. Among the 51 HSAs diagnosed, in 24 cases 
(47.1%) the localisation was determined as ‘atria’ or ‘atrial auricle’, and in five 
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cases (9.8%) as ‘the heart base’. Among the 31 ABTs diagnosed, 13 tumours 
(41.9%) were localised at the heart base. Moreover, in the group of 18 tumours 
localised at the heart base, all neoplasms were either ABT (n = 13) or HSA (n = 5), 
and in the group of 33 tumours localised within the atria (including the atrial 
auricles), 25 tumours were HSA, two were ABT and one case each was Kaposi-
like vascular tumour, sarcoma, solid carcinoma, fibroma, myxoma, and a tumour 
without precise histopathological diagnosis, respectively. 
Thirty dogs (27.27%) were crossbreeds. Among the purebred dogs (n = 
80), German Shepherds (20%; n = 22) and Boxers (16.36%; n = 18) were the 
most common, followed by Dachshunds (3.64%; n = 4), while other breeds were 
represented by three or less dogs (Fig. 3). 
 
Fig. 3. Breed prevalence of cardiac tumours in dogs (n = 109). ‘Other’ includes breeds represented 
by one dog: Golden Retriever, Cane Corso, American Staffordshire Terrier, Miniature Schnauzer, 
Pekingese, Pointer, Fox Terrier, Jagdterrier, Doberman Pinscher, Leonberger, Belgian Shepherd, 
Pug, Black Russian Terrier, Bouvier des Flandres, Weimaraner, Beagle, Boston Terrier 
 
Tumours were diagnosed in dogs aged 10 months to 18 years (mean 9.14 
years, SD = 2.82) with no significant differences between the number of males 
and females (P = 0.104; chi-square analysis). Among dogs presenting with HSA, 
a significantly higher number of males than females was noted (P = 0.005; chi-
square analysis), but that difference was not observed in the group of German 
Shepherds with HSA (P = 0.109; chi-square analysis). In dogs presenting with 
ABT and in Boxers with ABT no significant difference in sex distribution was 
noted (P = 0.467 and P = 0.781, respectively; chi-square analysis). For other 
types of tumours the case numbers were not sufficiently high to provide reliable 
results on sex distribution. 
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We found no differences in age between dogs of different sex (P = 0.969; 
Mann–Whitney U analysis), dogs presenting with different types of tumours (P = 
0.599; Kruskal–Wallis rank analysis), and dogs presenting with benign and ma-
lignant tumours (P = 0.776; Mann–Whitney U analysis). 
The immunohistochemical analysis of HSA showed intense (+++) expres-
sion of CD31 in all 11 cases (100%), which confirmed the endothelial origin of 
these tumours. Vimentin was expressed moderately (++) in 4/11 (36.4%) and in-
tensely (+++) in 7/11 (63.6%) cases, and the cytoplasmic expression of beta-
catenin was noted in all 11 tumours, including a weak (+) reaction in 5/11 cases 
(45.5%), a moderate (++) reaction in 4/11 cases (36.4%), and an intense (+++) 
reaction in 2/11 cases (18.2%). In each of the tumours examined at least one pro-
liferation marker (Ki-67, MCM-3, or MCM-7) showed a positive reaction. 
MCM-3 showed a higher expression than the other two proteins (P = 0.006; 
Friedman’s ANOVA). A positive expression of MCM-3 was noted in 10/11 
cases, including a weak (+) reaction in 5/11 cases (45.5%), a moderate (++) reac-
tion in 4/11 cases (36.4%), and an intense (+++) reaction in 1/11 (9.1%) case. A 
positive expression of both Ki-67 and MCM-7 was observed in 8/11 tumours, in-
cluding a weak (+) reaction in 7/11 cases (63.6%) and a moderate (++) reaction 
in 1/11 case (9.1%) (Figs 4–5). We observed no correlation in expression be-
tween the proteins examined (P > 0.05, Spearman’s correlation test). Only Ki-67 
showed a high positive correlation with the mitotic index (P < 0.05, r = 0.89, 
Spearman’s correlation test). 
 
Fig. 4. The percentage of haemangiosarcoma samples showing a positive reaction to the markers 
examined (n = 11); + = weak, ++ = moderate, +++ = intense reaction 
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Fig. 5. Microscopic pattern of haemangiosar-
coma. A: Tumour masses infiltrating the heart 
tissue. Haematoxylin and eosin (HE), ×200;  
B: Intense membranous expression of CD31, 
×400; C: Intense cytoplasmic expression of 
vimentin, × 400; D: Moderate cytoplasmic  
expression of beta-catenin, ×400; E: Moderate 
nuclear pattern of Ki-67, ×400; F: Moderate  
nuclear pattern of MCM-3, ×400; G: Moderate 
nuclear pattern of MCM-7, ×400 
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Discussion 
Along with the growing awareness of pet owners and the increasing life 
expectancy of animals, the number of tumours diagnosed in dogs (including car-
diac tumours) steadily rises (Ciaputa et al., 2013; Gesek et al., 2014). Ware and 
Hopper (1999) and Aupperle et al. (2007) noted primary cardiac neoplasms 
mainly in middle-aged large breed dogs, without a sex predisposition. Also in 
our study, 84 dogs (76.4%) were aged between 7 and 15 years and only one dog 
was older than 15 years. 
Only in cases of HSA could a distinct sex-related difference be observed 
(34 males vs. 17 females). Together with the equal male/female ratio in the entire 
dog cohort examined, and considering the results obtained by Sabattini and Bet-
tini (2009), this finding suggests a predisposition of males to develop cardiac 
HSA. Other authors (Ware and Hopper, 1999; Aupperle et al., 2007) did not find 
such a relationship. We observed a trend of HSA to localise within the atria and 
of ABT to localise at the heart base, which was also confirmed in other studies 
(Ware and Hopper, 1999; Aupperle et al., 2007; Noszczyk-Nowak et al., 2010). 
A considerable percentage of both HSA and ABT occurred in other localisations 
(including the ventricular walls) and a significant number of tumours had non-
defined localisations. This finding, together with the results of Rajagopalan et al. 
(2013) showing a low accuracy of preliminary diagnosis based on tumour local-
isation, does not allow us to draw far-reaching conclusions on the typical local-
isation of the tumours mentioned above. 
A high percentage of crossbreeds among all dogs and of German Shep-
herds and Boxers among purebred dogs, similar to that reported by Ciaputa et al. 
(2013) and Gesek et al. (2014), may be related to the popularity of these dogs in 
Poland, rather than to their predisposition to develop neoplastic lesions. On the 
other hand, HSA occurring in 14 out of 22 German Shepherds and ABT in 13 out 
of 18 Boxers in our study, together with the results obtained by other authors 
(Brown et al., 1985; Ware and Hopper, 1999; Sabattini and Bettini, 2009), and 
the low percentage of Dachshunds and the absence of Yorkshire Terriers (breeds 
also popular in Poland) among dogs affected by these tumours, may confirm the 
predisposition of the former breeds to develop certain types of tumours. It is sus-
pected that chronic hypoxia occurring in brachycephalic dogs may play a role in 
the stimulation of neoplastic growth originating from chemoreceptor cells 
(Noszczyk-Nowak et al., 2010), although not all dogs diagnosed with ABT were 
brachycephalic either according to the literature (Ware and Hopper, 1999) or in 
our study. 
In humans, benign cardiac tumours are more frequent than malignant ones, 
with myxomas being the most common benign neoplasms and myxosarcomas, 
HSA or non-differentiated sarcomas being the most common malignant tumours 
(Lam et al., 1993; Kim et al., 2008; Kumar et al., 2012; Wang et al., 2012). The 
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studies of Ware and Hopper (1999) and Aupperle et al. (2007) show that among 
tumours diagnosed in dogs post mortem, malignant tumours are more frequent, 
with HSA and ABT being the most common. A higher incidence of malignant 
tumours in dogs than in humans may be connected with the predisposition of 
dogs to developing malignant neoplasms (mainly HSA and ABT). 
HSA as a frequent tumour both in humans and animals was evaluated for 
various cell markers. According to the literature, cardiac HSA in humans shows 
positive expression of CD31, CD34, FLI-1, Ki-67, FVIIIRA, and p53 protein, 
and negative expression of SMA, desmin, S-100 protein, cytokeratin, c-kit pro-
tein, EGFR, and CD45 (Lam et al., 1993; Ge et al., 2011). 
In dogs, immunohistochemical studies of angiosarcoma included the ex-
pression of CD31 and FVIIIRA with a stronger and less diffuse reaction of the 
first marker (Ferrer et al., 1995; Bertazzolo et al., 2005). In the present study we 
also observed a strong reaction of CD31 in all tumour specimens, which con-
firms their endothelial origin. 
In a study of canine haemangioma and HSA, Sabattini and Bettini (2009) 
showed in the second group a distinct expression of vimentin, actin, FVIIIRA, 
CD117, VEGFR-3, and CD44 with a low expression of VEGFC. Similarly as in 
the above-mentioned research, in our study vimentin showed moderate or intense 
expression in all specimens examined. The lack of correlation observed between 
the expression of vimentin and that of proliferative proteins (Ki-67, MCM-3, and 
MCM-7) confirms the results obtained by Sabattini and Bettini (2009), showing 
a similar intensity of vimentin expression in both haemangioma and HSA. 
Although both Ki-67 and MCM family proteins play a role during cell di-
vision and DNA replication, the intensity of their expression in the examined tis-
sues may be diverse (Gambichler et al., 2009; Kreuter et al., 2009; Lau et al., 
2010; Saydam et al., 2010). Similarly, in this study the expression of three pro-
liferative proteins showed differences, but each examined tumour exhibited a 
positive reaction for at least one of the above-mentioned markers. The results of 
previous studies suggest that the expression of MCM family proteins can be used 
as a tool in differentiating between normal and neoplastic tissue (Saydam et al., 
2010) or between benign and malignant tumours (Gambichler et al., 2009; 
Kreuter et al., 2009). Lau et al. (2010) noted that high MCM-3 expression corre-
lates with poor prognosis in human melanoblastoma. Although the positive ex-
pression of all examined proliferation markers noted in the HSAs examined 
seems promising, the lack of correlation between MCM family proteins and the 
mitotic index or Ki-67 may suggest that those markers are not useful in the ex-
amination of canine HSA. Further studies with more samples of HSA and hae-
mangioma should be conducted to determine the usefulness of those proteins in 
the diagnosis of cardiac HSA in dogs. 
As mentioned before, the transformation of beta-catenin expression from 
membrane to cytoplasmic/nuclear is frequent in various canine neoplasms and 
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may be related to the neoplastic transformation of tissues (Nowak et al., 2007a,b; 
Stein et al., 2011). In this study the expression of beta-catenin was mainly cyto-
plasmic, indicating alterations in cell adhesion. Although in this study, as in the 
research of Nowak et al. (2007a), no correlation was observed between the ex-
pression of beta-catenin and that of proliferative proteins, the findings of other 
studies (Nowak et al., 2007b) show a positive correlation between those markers 
and suggest the possible role of beta-catenin in the proliferation of neoplastic cells. 
Recent studies show a high diagnostic potential of beta-catenin and MCM 
family proteins in the histopathological analysis of various malignant neoplasms 
(Nowak et al., 2007a,b; Gambichler et al., 2009; Kreuter et al., 2009; Lau et al., 
2010; Saydam et al., 2010; Stein et al., 2011; Galofaro et al., 2012). Extension of 
the examination protocol by MCM family proteins allows a more accurate as-
sessment of the proliferative potential of tumours. The analysis of beta-catenin 
expression with the subsequent examination of disorders in the Wnt/beta-catenin 
signalling pathway not only permits a better understanding of neoplastic patho-
genesis but also should lead to attempts to discover new antineoplastic drugs in-
fluencing that pathway (Nowak et al., 2007a). 
This study had several limitations. The research was conducted retrospec-
tively on the basis of examination records, which may increase the risk of diag-
nostic errors in the presented dataset. Information about the clinical signs, the 
time from initial diagnosis to death or euthanasia, and complete information 
about metastases could raise the value of the paper. Moreover, because of the 
relatively small number of HSA samples subjected to immunohistochemical ex-
amination, the lack of clinical data about those patients and the absence of hae-
mangioma samples serving for comparison, the conclusions drawn on the use of 
beta-catenin and MCM family proteins in the diagnostic process should be re-
garded only as preliminary results and a basis for further research. 
In conclusion, it can be established that the growing awareness of pet 
owners, the longer life expectancy of animals and the improved diagnostic possi-
bilities result in an increasing number of recognised cardiac neoplasms. Our re-
sults indicate a breed predisposition for specific tumours, i.e. HSA in German 
Shepherds and ABT in Boxers. 
Based on our results, MCM family proteins and beta-catenin can be used 
for the diagnosis of HSA in dogs, but this topic requires further, more detailed 
studies performed on a higher number of cases. 
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